India in contact with Gambia over deaths linked to cough syrup
3 min readBy PTI
NEW DELHI: India is in contact with the Gambia within the wake of a WHO report that doubtlessly linked the demise of 66 youngsters in that nation to 4 Indian-made cough syrups.
“That is a very very unfortunate story where children have died reportedly due to spurious drugs,” External Affairs Ministry spokesperson Arindam Bagchi mentioned when requested in regards to the difficulty.
He mentioned India is in contact with Gambia over it.
External Affairs Minister S Jaishankar held a telephonic dialog together with his Gambian counterpart Mamadou Tangara on Thursday, and conveyed “deepest condolences on the deaths of young children”.
“In a telecon with Gambian FM Dr.Mamadou Tangara, conveyed our deepest condolences on the deaths of young children recently. Underlined that matter is being seriously investigated by appropriate authorities. We agreed to remain in touch,” Jaishankar tweeted.
The authorities on Wednesday shaped a four-member panel of specialists to look at the small print and antagonistic occasion stories acquired from the WHO on the deaths.
“I think our health authorities issued a detailed statement in this regard a few days ago. Our drug regulatory authorities are undertaking investigation. Certain steps have been taken. We are also in touch with the government of the Gambia,” Bagchi mentioned.
The WHO had on September 29 had knowledgeable the Central Drugs Standard Control Organisation (CDSCO) that they have been offering technical help and recommendation to The Gambia, the place youngsters have died and the place a contributing issue was suspected to be using 4 medicines: Promethazine Oral Solution BP, KOFEXNALIN Baby Cough Syrup, MaKOFF Baby Cough Syrup and MaGrip n Cold Syrup.
They are manufactured and exported by Maiden Pharmaceuticals Ltd, Sonepat, Haryana, and the WHO had knowledgeable they could have been contaminated with Diethylene glycol or Ethylene glycol.
NEW DELHI: India is in contact with the Gambia within the wake of a WHO report that doubtlessly linked the demise of 66 youngsters in that nation to 4 Indian-made cough syrups.
“That is a very very unfortunate story where children have died reportedly due to spurious drugs,” External Affairs Ministry spokesperson Arindam Bagchi mentioned when requested in regards to the difficulty.
He mentioned India is in contact with Gambia over it.
External Affairs Minister S Jaishankar held a telephonic dialog together with his Gambian counterpart Mamadou Tangara on Thursday, and conveyed “deepest condolences on the deaths of young children”.
“In a telecon with Gambian FM Dr.Mamadou Tangara, conveyed our deepest condolences on the deaths of young children recently. Underlined that matter is being seriously investigated by appropriate authorities. We agreed to remain in touch,” Jaishankar tweeted.
The authorities on Wednesday shaped a four-member panel of specialists to look at the small print and antagonistic occasion stories acquired from the WHO on the deaths.
“I think our health authorities issued a detailed statement in this regard a few days ago. Our drug regulatory authorities are undertaking investigation. Certain steps have been taken. We are also in touch with the government of the Gambia,” Bagchi mentioned.
The WHO had on September 29 had knowledgeable the Central Drugs Standard Control Organisation (CDSCO) that they have been offering technical help and recommendation to The Gambia, the place youngsters have died and the place a contributing issue was suspected to be using 4 medicines: Promethazine Oral Solution BP, KOFEXNALIN Baby Cough Syrup, MaKOFF Baby Cough Syrup and MaGrip n Cold Syrup.
They are manufactured and exported by Maiden Pharmaceuticals Ltd, Sonepat, Haryana, and the WHO had knowledgeable they could have been contaminated with Diethylene glycol or Ethylene glycol.
